🌟 Meet the first 2 inspiring individuals who successfully reduced or quit #sleepingpills and the contribution of #health professionals in their journey! Discover these real-life based stories. #BenzoAwarenessDay (https://t.co/9GsuyXBwiO)
We are excited to introduce our first publication today: the Risks of Taking Sleeping Pills infographic, part of the BESAFE HORIZON EU project! Join us in raising awareness about the #benzodiazepines risks and discover the impact of healthy habits in our sleep #BenzoAwarenessDay
Scoping review shows #deprescribing recommendations are increasingly being incorporated into guidelines! 📈
However, detailed guidance on "how" to #deprescribe is still lacking: https://t.co/ChVLHbG0TH
More resources on "how" to #deprescribe here:
https://t.co/sx1AFeDwZd
Deprescribing networks worldwide are so inspiring to me and many others. Thanks @DrEmilyMcD for leading this report. Looking forward to future moments to network including #icod2!
Connecting with #deprescribing networks means more thought sharing, stronger initiatives & a greater impact.
We're so proud of our partnerships with @DeprescribeUS@DeprescribeAU@NDeprescribing!
Read the full article to know more about each network:
https://t.co/hG3YkmumZy
Interested in pharmacoepi, deprescribing and big data?
We're hiring 4 researchers for a research programme @RCSIPharmBioMol funded by @wellcometrust to develop methods and generate evidence on the effects of deprescribing.
Links in the next tweet, D/L 22nd Apr, RTs appreciated!
⏱️Tik Tok⏱️16 days before the call for abstracts closes! Would you like to share your research or clinical experience? Do you have ideas for a workshop? Submit them before February 29! #ICOD2024
🩺 How to omptimize the use of linezolid in clinical practice ? Read our last paper @ASpinewine :
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers https://t.co/0m6N78IeZI
ICOD2 is on its way! It's time to prepare our abstracts on #deprescribing to share them with this faulous international audience- Original research, clinical pearls and workshops.
📣 Attention Deprescribers! 📣
The call for abstracts for the ICOD2 is open! We are welcoming original research, clinical pearls and workshop proposals for this issue.
👉🏻 Please connect on https://t.co/LyZwvfsTh4 for more information, and submit before February 29th, 2024! 🥳
📣 Attention Deprescribers! 📣
The call for abstracts for the ICOD2 is open! We are welcoming original research, clinical pearls and workshop proposals for this issue.
👉🏻 Please connect on https://t.co/LyZwvfsTh4 for more information, and submit before February 29th, 2024! 🥳
Understanding how quality improvement interventions work is difficult without full intervention description
Pleased to share our work applying behavioural lens to surface active ingredients & causal assumptions of existing large-scale interventions (1/3) https://t.co/mWpj8NAiu0
Patient and public involvement in pragmatic trials:
The authors searched for pragmatic trials in MEDLINE and invited corresponding authors to participate in an online survey ➡️ https://t.co/IWD4rnsBmy
📢Today in @TheLancet: Beyond recos on the use of #benzodiazepines, recos on when and how to #deprescribe are needed. Beyond research on new drugs, we need research on approaches to deimplement practices that are widely used but jeopardize patients’ safety https://t.co/hdaZYjyYhE
We’re hiring x2! Research Coordinator (https://t.co/mrWe0G6sA2) to coordinate equity-focused BeSci & ImpSci qual studies & sys reviews in chronic disease, + Research Assistant (https://t.co/U3ora2oAS9) to support sys reviews & ethics apps in range of BeSci & ImplSci studies.